Quarterly report [Sections 13 or 15(d)]

Divestitures - Key Components of Net Income from Discontinued Operations (Details)

v3.25.2
Divestitures - Key Components of Net Income from Discontinued Operations (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Cost of revenues:        
Income (loss) before income tax expense $ 1,183,199 $ (1,719,222) $ 2,760,428 $ (202,979)
Income tax expense from discontinued operations 100,201 167,153 203,613 337,498
Net income (loss) from discontinued operations 1,082,998 (1,886,375) 2,556,815 (540,477)
Corporate Clinics        
Cost of revenues:        
Income tax expense from discontinued operations 100,201 167,153 203,613 337,498
Net income (loss) from discontinued operations 1,082,998 (1,886,375) 2,556,815 (540,477)
Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics        
Revenues:        
Total revenues 16,642,013 17,650,525 33,548,363 35,187,976
Cost of revenues:        
Total cost of revenues 5,551 14,282 11,723 25,846
Selling and marketing expenses 1,825,654 1,961,443 3,718,400 3,609,974
Depreciation and amortization 17,120 1,181,359 43,505 2,255,631
General and administrative expenses 11,857,995 14,777,444 24,128,217 27,701,829
Total selling, general and administrative expenses 13,700,769 17,920,246 27,890,122 33,567,434
Total net loss on disposition or impairment related to discontinued operations 1,752,494 1,434,658 2,885,852 1,796,486
Income (loss) from discontinued operations 1,183,199 (1,718,661) 2,760,666 (201,790)
Other expense, net 0 561 238 1,189
Income (loss) before income tax expense $ 1,183,199 $ (1,719,222) $ 2,760,428 $ (202,979)